scispace - formally typeset
S

Stephen K. Doberstein

Researcher at Johns Hopkins University School of Medicine

Publications -  30
Citations -  2965

Stephen K. Doberstein is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Cytokine & Actin. The author has an hindex of 15, co-authored 30 publications receiving 2805 citations. Previous affiliations of Stephen K. Doberstein include Johns Hopkins University & Exelixis.

Papers
More filters
Journal ArticleDOI

Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome

TL;DR: A comprehensive set of recombinant secreted proteins and the extracellular domains of transmembrane proteins, which constitute most of the protein components of the Extracellular space, are produced, useful for discovering new ligands and receptors and assessing the functional selectivity ofextracellular regulatory proteins.
Patent

OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION

TL;DR: In this article, the present invention relates to optimized Fc variants, methods for their generation, and antibodies and Fc fusions comprising optimized FC variants, and is related to our work.
Journal ArticleDOI

Mechanism of the interaction of human platelet profilin with actin

TL;DR: It is suggested that the in vitro effects on actin polymerization may be explained by a complex mechanism that includes weak capping of filament ends and catalytic poisoning of nucleation, and although platelets contain only 1profilin for every 5-10 actin molecules, these complex reactions may allow substoichiometric profilin to have an important influence on act in assembly.
Journal ArticleDOI

Dominant-Negative Inhibitors of Soluble TNF Attenuate Experimental Arthritis without Suppressing Innate Immunity to Infection

TL;DR: DN-TNFs are established as the first selective inhibitors of solTNF, demonstrate that inflammation in mouse arthritis models is primarily driven by solT NF, and suggest that the maintenance of tmTNF activity may improve the therapeutic index of future anti-inflammatory agents.